Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | KDM5A | P29375 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28504201 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL10021524 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL2138647 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL14666437 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL421573 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL424085 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL14666520 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL336544 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL10032088 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| SCHEMBL28500439 | 0.93 | LMNA (0.66) | LMNAMAPTMAPK1ALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| EP-4398930-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | Integrated Nanotherapeutics Inc. (CA) | 2024-07-17 | — | — | EP | disclosed |
| WO-2023035068-A1 | IMMUNOMODULATORY COMBINATIONS OF ANTIGEN AND DRUG-LIPID CONJUGATE | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2023-03-16 | — | — | WO | disclosed |
| US-20230012456-A1 | ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF | RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPEC (CN) | 2023-01-12 | — | — | US | disclosed |
| US-20220226480-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-07-21 | — | — | US | disclosed |
| EP-3941897-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | Integrated Nanotherapeutics Inc. (CA) | 2022-01-26 | — | — | EP | disclosed |
| WO-2021078249-A1 | ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF | 中国石油化工股份有限公司 | 2021-04-29 | — | — | WO | disclosed |
| WO-2020191477-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2020-10-01 | — | — | WO | disclosed |
| WO-2020191477-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | INTEGRATED NANOTHERAPEUTICS INC. (CA) | 2020-10-01 | — | — | WO | disclosed |
| US-8795547-B2 | Refrigeration oil from gas-to-liquid-derived and bio-derived triesters | CHEVRON U.S.A. INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-20120018667-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED DIESTERS | CHEVRON U.S.A., INC. | 2012-01-26 | — | — | US | disclosed |
| EP-2227529-A2 | REFRIGERATION OIL FROM GAS-TO-LIQUID DERIVED AND BIO-DERIVED TRIESTERS | Chevron U.S.A. Inc. (US) | 2010-09-15 | — | — | EP | disclosed |
| EP-2132283-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | Chevron U.S.A., Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| WO-2009085855-A2 | REFRIGERATION OIL FROM GAS-TO-LIQUID DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A. INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090159835-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A., INC. | 2009-06-25 | — | — | US | disclosed |
| US-20090159837-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED DIESTERS | CHEVRON U.S.A., INC. | 2009-06-25 | — | — | US | disclosed |
| US-20090159835-A1 | REFRIGERATION OIL FROM GAS-TO-LIQUID-DERIVED AND BIO-DERIVED TRIESTERS | CHEVRON U.S.A., INC. | 2009-06-25 | — | — | US | disclosed |
| US-7544645-B2 | Triester-based lubricants and methods of making same | CHEVRON U.S.A. INC. (US) | 2009-06-09 | — | — | US | disclosed |
| WO-2008124294-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | CHEVRON U.S.A. INC. (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248982-A1 | TRIESTER-BASED LUBRICANTS AND METHODS OF MAKING SAME | ADH5, ADH1A, ELOVL5 | LMNA 4663/4885MAPT 2206/4885MAPK1 4181/4885 |
| US-20240374734-A1 | Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate | LY96, CD74, TLR9 | LMNA 2079/4885MAPT 3671/4885MAPK1 3314/4885 |
| US-20230012456-A1 | ESTER COMPOUND AND PREPARATION METHOD THEREFOR AND USES THEREOF | ALOX12, FAR1, ALOX15 | LMNA 2270/4885MAPT 3357/4885MAPK1 1759/4885 |
| US-20220226480-A1 | LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY | LPXN, MLX, MGLL | LMNA 113/4885MAPT 1835/4885MAPK1 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.